CTO exits blood-testing startup of Elizabeth Holmes' partner, dubbed "Theranos 2.0"
annatonger · x · 2026-10-23
The blood-testing startup founded by Billy Evans, Elizabeth Holmes' partner, has lost its CTO—a key inventor on its patents.
Someone who spoke with Evans says he refers to the company as "Theranos 2.0," a label the company has rejected. Given the founder's ties to the Theranos scandal, the departure of its core technical figure deepens doubts about the startup's technology and prospects.
More from Companies & People
- Ollama CEO says enterprise AI is having its PC moment on This Week in AI — ollama · 2026-10-23
- Podium hits $150M AI ARR: the second time took 2.5 years vs 8 the first — ycombinator · 2026-10-23
- Omnix360 CEO on PedTech: Why AI Education Tools Must Put Pedagogy First — Cohere · 2026-10-23
- xAI launches Super Intelligence Partner Network with Microsoft, Google, NVIDIA among launch partners — NicoVerderosa · 2026-10-23
- Anthropic's Alex Albert: Claude Duet could matter more to small businesses than Square — alexalbert__ · 2026-10-23
- FAS launches a $174K Metascience Fellowship embedded high up at agencies like DOE — Afinetheorem · 2026-10-23